For many families, the lung cancer conversation starts with surgery: can the tumour be removed, and who will do it? In practice, surgery is one part of treatment, and for many patients diagnosed in Bangladesh, it is not the part that decides the outcome. What often matters more is how early the disease is staged, whether the tumour is tested for mutations, whether targeted or immune-based drugs are available, and how quickly radiotherapy can start. This guide compares lung cancer care in Bangladesh and India on those points, using recently published reports, so you can judge whether a second opinion or treatment in India makes sense for you. It is not a verdict on any hospital or doctor, and many patients are treated well at home.
Lung Cancer in Bangladesh: Where the Gaps Are
Bangladesh has capable oncologists and surgeons. But recent reports describe pressure on diagnosis, radiotherapy, and molecular testing, which are the areas where lung cancer care depends most on infrastructure. These figures come from news and review articles and can change, so confirm details locally.
Late Diagnosis
Lung cancer is among the more common cancers in Bangladeshi men. One 2025 review lists it at about 10.6 percent of cancers in adult males, and news reports say most patients seek help only after the disease is advanced. One clinical guide cites a median of roughly 121 days from first symptoms to diagnosis. Late diagnosis matters because surgery is generally reserved for early-stage disease.
Radiotherapy Capacity
Recent reports estimate roughly 30 to 37 radiotherapy machines nationwide, with only a handful working in the public sector and waits of several months at public hospitals. WHO guidance of one machine per million people would imply at least 170. The government has announced plans for 17 new machines, but timing is uncertain. This matters because radiotherapy is central to lung cancer care: alongside chemotherapy in locally advanced disease, as precise stereotactic treatment for selected patients who cannot have surgery, and for symptom control.
Molecular Testing and Targeted Drugs
Treating non-small cell lung cancer now depends on testing the tumour for EGFR, ALK, ROS1, and PD-L1. Earlier reports said EGFR testing was unavailable in Bangladesh, and recent guides still describe testing as not widely available. This may have improved, so ask your oncologist directly whether your tumour has been tested and where. Without results, patients often receive standard chemotherapy by default.
Cost at Home
A lung cancer operation at a private hospital is reported at Tk 4 lakh to Tk 6 lakh, before chemotherapy, radiotherapy, or drugs are added.
Lung Cancer Treatment in India: What Changes Beyond Surgery
Surgery itself is not dramatically different between the two countries. The difference lies in the surrounding system: staging, testing, drugs, radiation technology, and a team that decides together. Larger Indian cancer centres are built around this system.
Complete Staging Before Any Decision
PET-CT, brain MRI, and a biopsy with immunohistochemistry are standard at larger Indian cancer centres. Staging decides whether surgery is the right first step at all, or whether chemoradiotherapy or systemic treatment should come first.
Molecular Profiling and Targeted Therapy
Major centres test for EGFR, ALK, ROS1, and other drivers, then prescribe matched tablets where a mutation is found. EGFR mutations are more common in people of Asian ancestry and in non-smokers, which makes testing especially relevant for South Asian patients. Indian-made biosimilars have also lowered the cost of several targeted and immune drugs in recent years.
Immunotherapy
For tumours without a targetable mutation, PD-L1 testing guides immunotherapy such as pembrolizumab, alone or with chemotherapy. Listing guides estimate USD 14,000 to USD 24,000 for a course in India, but the real figure depends on the drug, the number of cycles, and any biosimilar use.
Radiation Technology
India's larger centres offer IMRT, stereotactic radiotherapy, and CyberKnife. Listing guides estimate lung radiotherapy at roughly USD 3,800 to USD 6,800 and CyberKnife at USD 5,500 to USD 7,800, while other estimates for Bangladeshi patients start nearer USD 3,000.
A Multidisciplinary Tumour Board
At accredited centres, a surgeon, medical oncologist, radiation oncologist, radiologist, and pathologist review each case together before treatment starts. For lung cancer this is valuable, because the best sequence of surgery, radiation, and drugs depends on all of them. For a closer look at how this works, read: How Cancer Therapies in India for Oman Patients Are Selected Based on Cancer Type
Lung Cancer in Bangladesh vs India at a Glance
| Factor | Bangladesh (recent reports) | India (larger accredited centres) |
|---|---|---|
| Stage at diagnosis | Often advanced | Staging with PET-CT and brain MRI is standard |
| Radiotherapy access | About 30 to 37 machines nationally, long public waits | IMRT, stereotactic, and CyberKnife widely available |
| Molecular testing (EGFR, ALK, PD-L1) | Limited or not widely available, confirm locally | Routine at major centres |
| Surgery cost | Tk 4 to 6 lakh at private hospitals | About USD 3,000 to USD 7,000 (estimate), up to USD 12,000 for pneumonectomy |
| Radiotherapy cost | Varies, long waits at public centres | About USD 3,000 to USD 6,800 |
| Immunotherapy | Depends on testing and affordability | About USD 14,000 to USD 24,000 per course (listing estimate) |
The table shows that surgery costs are not the main difference. The gap is in testing, drugs, and radiotherapy access.
Is Travelling to India Right for You?
A trip is not right for everyone. An honest look at your situation helps you avoid unnecessary travel and spend your energy where it can change the plan.
When It Is Worth Considering
- You were diagnosed recently and your tumour has not had molecular testing
- You face a long radiotherapy wait and the delay worries you
- You want a second opinion before major surgery or a long chemotherapy course
- Your disease is locally advanced, where combined treatment options matter most
When to Pause and Ask First
- Your disease is very advanced and you are unwell, so travel may be hard and the plan may not change
- Your current oncologist is already running full testing and can start treatment promptly
In these cases, start with a record review. Sending your reports for opinion costs little and can show whether travelling would change anything.
What to Send Before You Decide
Share your biopsy report with immunohistochemistry, CT chest and abdomen, PET-CT if done, brain MRI, blood tests, any EGFR, ALK, or PD-L1 results, and your treatment history so far.
Practical Planning
Kolkata is the nearest major city, about an hour by air from Dhaka, though complex cases are sometimes better matched to larger centres in Chennai or Delhi. You will need an Indian medical visa supported by a hospital invitation letter. Keep your Bangladeshi oncologist informed, because they usually remain part of your care after you return.
How Karetrip Supports Bangladeshi Lung Cancer Patients
Traveling from Bangladesh to India for lung cancer treatment is a major decision often made under urgent, stressful circumstances. Patients and their families frequently face confusion over which hospital to choose, delays in obtaining medical visas, and concerns about hidden hospital costs. Karetrip serves as a dedicated medical care coordinator, organizing your entire clinical pathway and travel logistics before you depart Dhaka, Chittagong, or Sylhet, ensuring you receive timely, stage-appropriate cancer care in India.
How Karetrip Manages Your Care at Every Step
-
Pre-Travel Record Review and Second Opinions
Lung cancer treatment depends heavily on precise histology and genetic profiling. Our medical team collects your chest CT scans, PET-CT reports, biopsy findings, and molecular biomarker tests (such as EGFR, ALK, KRAS, and PD-L1). We share these files directly with senior thoracic oncologists and pulmonologists at top Indian hospitals to verify whether surgery (like minimally invasive VATS), stereotactic radiation, immunotherapy, or targeted daily pills offer the highest chance of control. -
Targeted Hospital Shortlisting Across Indian Metros
Rather than routing you to a clinic based on generic advice, Karetrip presents accredited hospitals (JCI and NABH) best suited to your clinical stage and preferred travel hub whether that means high-volume thoracic surgical centers in Kolkata (such as Apollo, Medica, or Tata Medical Center), advanced proton/radiotherapy centers in Chennai, or comprehensive cancer institutes in Delhi NCR. You receive transparent, itemized cost estimates covering consultations, PET-CT repeats, hospital bed categories, and systemic therapies. -
Fast-Track Medical Visa (IVAC) Documentation
Obtaining an Indian Medical Visa (MED) and Medical Attendant Visas (MED-X) for accompanying family members requires verified hospital documentation. Karetrip liaises directly with the treating hospital's international desk to issue an official, stamped Medical Visa Invitation Letter quickly, reducing processing delays through Indian Visa Application Centres (IVAC) across Bangladesh. -
Hygienic Extended-Stay Lodging and Transfers
Cancer treatments whether a surgical lung resection or multiple cycles of chemotherapy and immunotherapy often require stays spanning several weeks. Karetrip arranges sanitized, elevator-accessible, fully furnished apartments or guest houses within minutes of your hospital. We also coordinate direct airport pick-ups from Netaji Subhash Chandra Bose International Airport (CCU) or Indira Gandhi International Airport (DEL) to eliminate travel fatigue. -
Dedicated On-Ground and Language Support
Arriving in a busy hospital in another country can be overwhelming. A dedicated care coordinator assists you during outpatient registrations, helps navigate diagnostics and pharmacy billing, and ensures language is never a barrier, facilitating smooth communication between you and your treating oncology team. -
Continuity of Care and Handover to Your Home Oncologist
Cancer care continues long after you return to Bangladesh. Before you fly home, your coordinator compiles your complete medical file including high-resolution digital imaging, histopathology slides/blocks, surgery notes, and detailed chemotherapy or oral targeted therapy schedules. This allows your local oncologist in Bangladesh to oversee follow-up blood work, manage side effects, and coordinate future imaging seamlessly.
Chat with our Medical care assistant, RUA, for quick guidance and support and take the first step toward a clear lung cancer treatment plan.